Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NAFRONYL: 116 Adverse Event Reports & Safety Profile

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
116
Total FAERS Reports
24 (20.7%)
Deaths Reported
63
Hospitalizations
116
As Primary/Secondary Suspect
10
Life-Threatening
13
Disabilities

First Report: 20011231 · Latest Report: 20210408

What Are the Most Common NAFRONYL Side Effects?

#1 Most Reported
Acute kidney injury
22 reports (19.0%)
#2 Most Reported
Toxicity to various agents
19 reports (16.4%)
#3 Most Reported
Hepatic cytolysis
19 reports (16.4%)

All NAFRONYL Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Acute kidney injury 22 19.0% 3 20
Hepatic cytolysis 19 16.4% 19 13
Toxicity to various agents 19 16.4% 19 13
Acute pulmonary oedema 18 15.5% 18 12
Cardiac disorder 17 14.7% 17 11
Lactic acidosis 14 12.1% 2 9
Synovitis 14 12.1% 14 13
Cerebral haemorrhage 13 11.2% 0 0
Anaemia 12 10.3% 0 0
Coronary artery stenosis 12 10.3% 12 11
Encephalopathy 12 10.3% 12 7
Renal cell carcinoma 12 10.3% 0 0
Respiratory depression 12 10.3% 12 7
Drug abuse 11 9.5% 11 10
Hyperkalaemia 11 9.5% 1 11
Intentional self-injury 11 9.5% 11 10
Anuria 9 7.8% 0 9
Cardio-respiratory arrest 9 7.8% 9 7
Hypocalcaemia 9 7.8% 0 9
Hypomagnesaemia 9 7.8% 0 9

Who Reports NAFRONYL Side Effects? Age & Gender Data

Gender: 24.1% female, 75.9% male. Average age: 65.8 years. Most reports from: FR. View detailed demographics →

Is NAFRONYL Getting Safer? Reports by Year

YearReportsDeathsHosp.
2001 1 0 1
2011 2 0 2
2012 1 1 1
2013 4 0 1
2014 12 0 0
2015 2 2 2
2016 25 21 17
2017 9 0 9
2018 23 0 23
2019 7 0 5
2020 14 0 0
2021 1 0 0

View full timeline →

What Is NAFRONYL Used For?

IndicationReports
Product used for unknown indication 63
Intermittent claudication 13
Thromboangiitis obliterans 12
Peripheral vascular disorder 8
Peripheral arterial occlusive disease 7

NAFRONYL vs Alternatives: Which Is Safer?

NAFRONYL vs NAFTIFINE NAFRONYL vs NAGLAZYME NAFRONYL vs NALBUPHINE NAFRONYL vs NALDEMEDINE NAFRONYL vs NALMEFENE NAFRONYL vs NALOXEGOL OXALATE NAFRONYL vs NALOXONE NAFRONYL vs NALOXONE\OXYCODONE NAFRONYL vs NALOXONE\TILIDINE NAFRONYL vs NALTREXONE

Official FDA Label for NAFRONYL

Official prescribing information from the FDA-approved drug label.